Equillium, Inc. - Common Stock (NQ:EQ)

1.427 -0.013 (-0.91%)

Delayed Quote Updated: 2:02 PM EDT, Oct 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Equillium, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Equillium Announces Multiple Abstracts Accepted for Presentation at ACR Convergence 2021

September 30, 2021

From Equillium, Inc.

Via Business Wire

Equillium to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference

September 22, 2021

From Equillium, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For September 15, 2021 ↗

September 15, 2021

Upgrades For Alcoa Corp (NYSE:

Via Benzinga

Equillium to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

September 08, 2021

From Equillium, Inc.

Via Business Wire

60 Biggest Movers From Yesterday ↗

August 24, 2021

Gainers Trillium Therapeutics Inc. (NASDAQ: TRIL) shares jumped 188.8% to close at $17.59 on Monday after the company agreed to be acquired by Pfizer for $18.50 per share,...

Via Benzinga

Equillium's Itolizumab Reduces Urine Protein In Lupus Patients ↗

August 12, 2021

Equillium Inc (NASDAQ: EQ) announced additional data from the Type A portion of the EQUALISE Phase 1b study of itolizumab in systemic lupus erythematosus (SLE) and...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

August 11, 2021

Gainers Hims & Hers Health (NYSE:HIMS)...

Via Benzinga

Equillium Announces Update to EQUALISE Study of Itolizumab in Patients with Systemic Lupus Erythematosus and Lupus Nephritis

August 11, 2021

From Equillium, Inc.

Via Business Wire

Equillium Reports Second Quarter 2021 Financial Results and Provides Clinical Development Update

August 10, 2021

From Equillium, Inc.

Via Business Wire

Equillium to Present at the BTIG Virtual Biotechnology Conference

August 05, 2021

From Equillium, Inc.

Via Business Wire

Equillium's Single Phase 3 Study In aGVHD To Support US Filing Of Itolizumab ↗

July 13, 2021

Equillium Inc (NASDAQ: EQ) completed an End-of-Phase 1 meeting with the FDA, confirming to advance itolizumab into a single Phase 3 pivotal study in first-line...

Via Benzinga

The Daily Biotech Pulse: Equillium Issues Positive Regulatory Update, Biogen In-Licenses Multiple Sclerosis Drug, Aridis Releases COVID-19 Antibody Cocktail Data ↗

July 13, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 12) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

July 12, 2021

Gainers SCWorx (NASDAQ:WORX) shares rose...

Via Benzinga

64 Biggest Movers From Friday ↗

June 14, 2021

Gainers Kanzhun Limited (NASDAQ: BZ) shares climbed 95.8% to close at $37.20 on Friday after the company priced its IPO at $19 per share. Novan, Inc. (NASDAQ: NOVN) shares gained...

Via Benzinga

Topics Initial Public Offering

12 Health Care Stocks Moving In Friday's Intraday Session ↗

June 11, 2021

Gainers Novan (NASDAQ:NOVN) stock rose 71.04% to $15.46 during Friday's regular session. As of 12:30 EST, Novan's stock is trading at a volume of 109.3 million,...

Via Benzinga

Equillium's Itolizumab Shows Rapid, Durable Responses In Graft-Versus-Host-Disease Patients ↗

June 11, 2021

Equillium Inc (NASDAQ: EQ) has announced positive topline data from the Phase 1b EQUATE study evaluating itolizumab in first-line acute graft-versus-host-disease (...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

June 09, 2021

Gainers Aethlon Medical (NASDAQ:AEMD) stock rose 248.41% to $7.7 during Wednesday's pre-market session. The market value of their outstanding shares is at $93.4...

Via Benzinga

46 Biggest Movers From Yesterday ↗

April 21, 2021

Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) shares jumped 27.3% to close at $9.79 on Tuesday after the company reported inducement grants. The company recently said it...

Via Benzinga

The Week Ahead In Biotech: Biogen, Alexion And Vertex FDA Decisions, Multiple Conference Presentations On The Deck ↗

June 07, 2021

Biopharma stocks advanced in the truncated week ended June 4 amid the broader market strength. The American Society for Clinical Oncology meeting got underway during the week,...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.